 | K0Z | Name: | (~{E})-~{N}-(5-bromanyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide | Formula: | C13 H9 Br N4 O3 S | SMILES: | COc1cc(ccc1O)C=C(C#N)C(=O)Nc2sc(Br)nn2 | InChi: | InChI=1S/C13H9BrN4O3S/c1-21-10-5-7(2-3-9(10)19)4-8(6-15)11(20)16-13-18-17-12(14)22-13/h2-5,19H,1H3,(H,16,18,20)/b8-4+ | Definition date: | 2019-04-14 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (~{E})-~{N}-(5-bromanyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enamide |
|
 | K1B | Name: | (~{E})-~{N}-(5-bromanyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-nitro-4-oxidanyl-phenyl)prop-2-enamide | Formula: | C12 H6 Br N5 O4 S | SMILES: | Oc1ccc(C=C(C#N)C(=O)Nc2sc(Br)nn2)cc1[N+]([O-])=O | InChi: | InChI=1S/C12H6BrN5O4S/c13-11-16-17-12(23-11)15-10(20)7(5-14)3-6-1-2-9(19)8(4-6)18(21)22/h1-4,19H,(H,15,17,20)/b7-3+ | Definition date: | 2019-04-15 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (~{E})-~{N}-(5-bromanyl-1,3,4-thiadiazol-2-yl)-2-cyano-3-(3-nitro-4-oxidanyl-phenyl)prop-2-enamide |
|
 | EVC | Name: | N-ethyl-2-[[4-[[4-(4-methylpiperazin-1-yl)-3-(2-morpholin-4-ylethoxy)phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide | Formula: | C28 H39 N9 O4 S | SMILES: | CCN[S](=O)(=O)c1ccccc1Nc2ncnc(Nc3ccc(N4CCN(C)CC4)c(OCCN5CCOCC5)c3)n2 | InChi: | InChI=1S/C28H39N9O4S/c1-3-31-42(38,39)26-7-5-4-6-23(26)33-28-30-21-29-27(34-28)32-22-8-9-24(37-12-10-35(2)11-13-37)25(20-22)41-19-16-36-14-17-40-18-15-36/h4-9,20-21,31H,3,10-19H2,1-2H3,(H2,29,30,32,33,34) | Definition date: | 2020-02-05 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | ~{N}-ethyl-2-[[4-[[4-(4-methylpiperazin-1-yl)-3-(2-morpholin-4-ylethoxy)phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide |
|
 | EVL | Name: | N-ethyl-2-[[4-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide | Formula: | C28 H39 N9 O3 S | SMILES: | CCN[S](=O)(=O)c1ccccc1Nc2ncnc(Nc3ccc(N4CCC(CC4)N5CCN(C)CC5)c(OC)c3)n2 | InChi: | InChI=1S/C28H39N9O3S/c1-4-31-41(38,39)26-8-6-5-7-23(26)33-28-30-20-29-27(34-28)32-21-9-10-24(25(19-21)40-3)37-13-11-22(12-14-37)36-17-15-35(2)16-18-36/h5-10,19-20,22,31H,4,11-18H2,1-3H3,(H2,29,30,32,33,34) | Definition date: | 2020-02-05 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | ~{N}-ethyl-2-[[4-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide |
|
 | EVR | Name: | 2-[[5-[2-(3,5-dimethoxyphenyl)ethyl]-2-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]pyrimidin-4-yl]amino]-N-ethyl-benzenesulfonamide | Formula: | C39 H52 N8 O5 S | SMILES: | CCN[S](=O)(=O)c1ccccc1Nc2nc(Nc3ccc(N4CCC(CC4)N5CCN(C)CC5)c(OC)c3)ncc2CCc6cc(OC)cc(OC)c6 | InChi: | InChI=1S/C39H52N8O5S/c1-6-41-53(48,49)37-10-8-7-9-34(37)43-38-29(12-11-28-23-32(50-3)26-33(24-28)51-4)27-40-39(44-38)42-30-13-14-35(36(25-30)52-5)47-17-15-31(16-18-47)46-21-19-45(2)20-22-46/h7-10,13-14,23-27,31,41H,6,11-12,15-22H2,1-5H3,(H2,40,42,43,44) | Definition date: | 2020-02-05 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 2-[[5-[2-(3,5-dimethoxyphenyl)ethyl]-2-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]pyrimidin-4-yl]amino]-~{N}-ethyl-benzenesulfonamide |
|
 | O6W | Name: | 4,4,4-tris(fluoranyl)-~{N}-isoquinolin-6-yl-butane-1-sulfonamide | Formula: | C13 H13 F3 N2 O2 S | SMILES: | FC(F)(F)CCC[S](=O)(=O)Nc1ccc2cnccc2c1 | InChi: | InChI=1S/C13H13F3N2O2S/c14-13(15,16)5-1-7-21(19,20)18-12-3-2-11-9-17-6-4-10(11)8-12/h2-4,6,8-9,18H,1,5,7H2 | Definition date: | 2020-02-17 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 4,4,4-tris(fluoranyl)-~{N}-isoquinolin-6-yl-butane-1-sulfonamide |
|
 | O6Z | Name: | ~{N}-(1~{H}-indazol-5-yl)butane-1-sulfonamide | Formula: | C11 H15 N3 O2 S | SMILES: | CCCC[S](=O)(=O)Nc1ccc2[nH]ncc2c1 | InChi: | InChI=1S/C11H15N3O2S/c1-2-3-6-17(15,16)14-10-4-5-11-9(7-10)8-12-13-11/h4-5,7-8,14H,2-3,6H2,1H3,(H,12,13) | Definition date: | 2020-02-17 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | ~{N}-(1~{H}-indazol-5-yl)butane-1-sulfonamide |
|
 | MJD | Name: | (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl {(2S,3R)-1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-methylpropyl)({2-[(propan-2-yl)amino]-1,3-benzoxazol-6-yl}sulfonyl)amino]butan-2-yl}carbamate | Formula: | C33 H42 F2 N4 O8 S | SMILES: | C12CC3COC1OCC2C3OC(=O)NC(Cc4cc(cc(c4)F)F)C(O)CN(CC(C)C)S(=O)(=O)c5cc6c(cc5)nc(o6)NC(C)C | InChi: | InChI=1S/C33H42F2N4O8S/c1-17(2)13-39(48(42,43)23-5-6-26-29(12-23)46-32(37-26)36-18(3)4)14-28(40)27(9-19-7-21(34)11-22(35)8-19)38-33(41)47-30-20-10-24-25(30)16-45-31(24)44-15-20/h5-8,11-12,17-18,20,24-25,27-28,30-31,40H,9-10,13-16H2,1-4H3,(H,36,37)(H,38,41)/t20-,24-,25-,27+,28-,30+,31+/m1/s1 | Definition date: | 2019-04-04 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (3S,3aR,5R,7aS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-yl {(2S,3R)-1-(3,5-difluorophenyl)-3-hydroxy-4-[(2-methylpropyl)({2-[(propan-2-yl)amino]-1,3-benzoxazol-6-yl}sulfonyl)amino]butan-2-yl}carbamate |
|
 | QPV | Name: | 3-chloro-N-{4-[1-(propylcarbamoyl)cyclobutyl]phenyl}benzamide | Formula: | C21 H23 Cl N2 O2 | SMILES: | C(C3(c1ccc(cc1)NC(c2cccc(c2)Cl)=O)CCC3)(NCCC)=O | InChi: | InChI=1S/C21H23ClN2O2/c1-2-13-23-20(26)21(11-4-12-21)16-7-9-18(10-8-16)24-19(25)15-5-3-6-17(22)14-15/h3,5-10,14H,2,4,11-13H2,1H3,(H,23,26)(H,24,25) | Definition date: | 2019-12-06 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 3-chloro-N-{4-[1-(propylcarbamoyl)cyclobutyl]phenyl}benzamide |
|
 | R1V | Name: | N-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-L-glutamic acid | Formula: | C15 H25 N O4 | SMILES: | CC(C)=[C@H]CCC(C)=[C@H]CNC(C(O)=O)CCC(=O)O | InChi: | InChI=1S/C15H25NO4/c1-11(2)5-4-6-12(3)9-10-16-13(15(19)20)7-8-14(17)18/h5,9,13,16H,4,6-8,10H2,1-3H3,(H,17,18)(H,19,20)/b12-9+/t13-/m0/s1 | Definition date: | 2020-01-23 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | N-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-L-glutamic acid |
|
 | R4S | Name: | N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropanecarboxamide | Formula: | C18 H22 F N7 O2 | SMILES: | n1cc(cn1CCO)Nc2ncc(c(n2)N3CC4C(C3)(C4)NC(C5CC5)=O)F | InChi: | InChI=1S/C18H22FN7O2/c19-14-7-20-17(22-13-6-21-26(9-13)3-4-27)23-15(14)25-8-12-5-18(12,10-25)24-16(28)11-1-2-11/h6-7,9,11-12,27H,1-5,8,10H2,(H,24,28)(H,20,22,23)/t12-,18-/m1/s1 | Definition date: | 2020-01-30 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropanecarboxamide |
|
 | R4V | Name: | (1S)-2,2-difluoro-N-[(1S,5R,6R)-3-{5-fluoro-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-6-methyl-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide | Formula: | C18 H20 F3 N7 O | SMILES: | n1c(ncc(c1N3CC2C(C2C)(C3)NC(C4C(F)(C4)F)=O)F)Nc5cn(nc5)C | InChi: | InChI=1S/C18H20F3N7O/c1-9-12-7-28(8-17(9,12)26-15(29)11-3-18(11,20)21)14-13(19)5-22-16(25-14)24-10-4-23-27(2)6-10/h4-6,9,11-12H,3,7-8H2,1-2H3,(H,26,29)(H,22,24,25)/t9-,11+,12+,17+/m1/s1 | Definition date: | 2020-01-30 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (1S)-2,2-difluoro-N-[(1S,5R,6R)-3-{5-fluoro-2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-6-methyl-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide |
|
 | R4Y | Name: | (1S,2S)-2-cyano-N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide | Formula: | C19 H21 F N8 O2 | SMILES: | N(c1cnn(CCO)c1)c2nc(c(cn2)F)N4CC3C(C3)(C4)NC(C5C(C#N)C5)=O | InChi: | InChI=1S/C19H21FN8O2/c20-15-7-22-18(24-13-6-23-28(9-13)1-2-29)25-16(15)27-8-12-4-19(12,10-27)26-17(30)14-3-11(14)5-21/h6-7,9,11-12,14,29H,1-4,8,10H2,(H,26,30)(H,22,24,25)/t11-,12-,14+,19-/m1/s1 | Definition date: | 2020-01-30 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (1S,2S)-2-cyano-N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide |
|
 | R5D | Name: | (1R,2R)-2-cyano-N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide | Formula: | C19 H21 F N8 O2 | SMILES: | N(c1cnn(CCO)c1)c2nc(c(cn2)F)N4CC3C(C3)(C4)NC(C5C(C5)C#N)=O | InChi: | InChI=1S/C19H21FN8O2/c20-15-7-22-18(24-13-6-23-28(9-13)1-2-29)25-16(15)27-8-12-4-19(12,10-27)26-17(30)14-3-11(14)5-21/h6-7,9,11-12,14,29H,1-4,8,10H2,(H,26,30)(H,22,24,25)/t11-,12+,14+,19+/m0/s1 | Definition date: | 2020-01-30 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (1R,2R)-2-cyano-N-[(1S,5R)-3-(5-fluoro-2-{[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-1-yl]cyclopropane-1-carboxamide |
|
 | R67 | Name: | 3-(methylsulfonyl)-2-oxopropanoic acid | Formula: | C4 H6 O5 S | SMILES: | CS(CC(=O)C(O)=O)(=O)=O | InChi: | InChI=1S/C4H6O5S/c1-10(8,9)2-3(5)4(6)7/h2H2,1H3,(H,6,7) | Definition date: | 2020-01-31 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | 3-(methylsulfonyl)-2-oxopropanoic acid |
|
 | R7V | Name: | (1R,3S,4R)-4-[(3aR,9bR)-9b-[(4-fluorophenyl)sulfonyl]-7-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-1,2,3a,4,5,9b-hexahydro-3H-benzo[e]indole-3-carbonyl]-3-methylcyclohexane-1-carboxylic acid | Formula: | C30 H29 F8 N O5 S | SMILES: | c1c(cc2c(c1)C3(C(CC2)N(CC3)C(=O)C4CCC(CC4C)C(O)=O)S(c5ccc(cc5)F)(=O)=O)C(C(F)(F)F)(F)C(F)(F)F | InChi: | InChI=1S/C30H29F8NO5S/c1-16-14-18(26(41)42)2-9-22(16)25(40)39-13-12-27(45(43,44)21-7-5-20(31)6-8-21)23-10-4-19(15-17(23)3-11-24(27)39)28(32,29(33,34)35)30(36,37)38/h4-8,10,15-16,18,22,24H,2-3,9,11-14H2,1H3,(H,41,42)/t16-,18+,22+,24+,27+/m0/s1 | Definition date: | 2020-02-06 | Last modified: | 2020-04-03 | Release date: | 2020-04-08 | Identifier: | (1R,3S,4R)-4-[(3aR,9bR)-9b-[(4-fluorophenyl)sulfonyl]-7-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-1,2,3a,4,5,9b-hexahydro-3H-benzo[e]indole-3-carbonyl]-3-methylcyclohexane-1-carboxylic acid |
|
 | RU4 | Name: | 4-(1,2,3-thiadiazol-4-yl)phenyl ethylcarbamate | Formula: | C11 H11 N3 O2 S | SMILES: | N(C(Oc1ccc(cc1)c2nnsc2)=O)CC | InChi: | InChI=1S/C11H11N3O2S/c1-2-12-11(15)16-9-5-3-8(4-6-9)10-7-17-14-13-10/h3-7H,2H2,1H3,(H,12,15) | Definition date: | 2020-02-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 4-(1,2,3-thiadiazol-4-yl)phenyl ethylcarbamate |
|
 | RUV | Name: | 4-(acetylamino)-N-(4H-1,2,4-triazol-4-yl)benzamide | Formula: | C11 H11 N5 O2 | SMILES: | N(C(C)=O)c1ccc(cc1)C(=O)Nn2cnnc2 | InChi: | InChI=1S/C11H11N5O2/c1-8(17)14-10-4-2-9(3-5-10)11(18)15-16-6-12-13-7-16/h2-7H,1H3,(H,14,17)(H,15,18) | Definition date: | 2020-02-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 4-(acetylamino)-N-(4H-1,2,4-triazol-4-yl)benzamide |
|
 | RUY | Name: | 4-(piperidin-1-yl)-1,2,5-oxadiazol-3-amine | Formula: | C7 H12 N4 O | SMILES: | N2(c1nonc1N)CCCCC2 | InChi: | InChI=1S/C7H12N4O/c8-6-7(10-12-9-6)11-4-2-1-3-5-11/h1-5H2,(H2,8,9) | Definition date: | 2020-02-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 4-(piperidin-1-yl)-1,2,5-oxadiazol-3-amine |
|
 | RV4 | Name: | N-{4-[(morpholin-4-yl)methyl]phenyl}acetamide | Formula: | C13 H18 N2 O2 | SMILES: | N(C(C)=O)c1ccc(cc1)CN2CCOCC2 | InChi: | InChI=1S/C13H18N2O2/c1-11(16)14-13-4-2-12(3-5-13)10-15-6-8-17-9-7-15/h2-5H,6-10H2,1H3,(H,14,16) | Definition date: | 2020-02-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-{4-[(morpholin-4-yl)methyl]phenyl}acetamide |
|
 | S3O | Name: | N-[5-(2,3-dimethylphenyl)-1,2,3,4-tetrahydro-1,6-naphthyridin-7-yl]acetamide | Formula: | C18 H21 N3 O | SMILES: | C2CNc1cc(NC(=O)C)nc(c1C2)c3cccc(c3C)C | InChi: | InChI=1S/C18H21N3O/c1-11-6-4-7-14(12(11)2)18-15-8-5-9-19-16(15)10-17(21-18)20-13(3)22/h4,6-7,10,19H,5,8-9H2,1-3H3,(H,20,21,22) | Definition date: | 2019-10-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-[5-(2,3-dimethylphenyl)-1,2,3,4-tetrahydro-1,6-naphthyridin-7-yl]acetamide |
|
 | GN6 | Name: | 5-(2,3-dichlorophenyl)[1,2,4]triazolo[1,5-a]pyridin-2-amine | Formula: | C12 H8 Cl2 N4 | SMILES: | n12nc(nc1cccc2c3cccc(c3Cl)Cl)N | InChi: | InChI=1S/C12H8Cl2N4/c13-8-4-1-3-7(11(8)14)9-5-2-6-10-16-12(15)17-18(9)10/h1-6H,(H2,15,17) | Definition date: | 2019-10-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 5-(2,3-dichlorophenyl)[1,2,4]triazolo[1,5-a]pyridin-2-amine |
|
 | C7 | Name: | N-{2-[3-(hydroxyamino)-3-oxopropyl]phenyl}-3-(trifluoromethyl)benzamide | Formula: | C17 H15 F3 N2 O3 | SMILES: | O=C(NO)CCc1c(cccc1)NC(c2cc(ccc2)C(F)(F)F)=O | InChi: | InChI=1S/C17H15F3N2O3/c18-17(19,20)13-6-3-5-12(10-13)16(24)21-14-7-2-1-4-11(14)8-9-15(23)22-25/h1-7,10,25H,8-9H2,(H,21,24)(H,22,23) | Definition date: | 2019-03-27 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-{2-[3-(hydroxyamino)-3-oxopropyl]phenyl}-3-(trifluoromethyl)benzamide |
|
 | DYR | Name: | 2-carbazol-9-yl-N-(2-chloranyl-6-cyano-phenyl)ethanamide | Formula: | C21 H14 Cl N3 O | SMILES: | Clc1cccc(C#N)c1NC(=O)Cn2c3ccccc3c4ccccc24 | InChi: | InChI=1S/C21H14ClN3O/c22-17-9-5-6-14(12-23)21(17)24-20(26)13-25-18-10-3-1-7-15(18)16-8-2-4-11-19(16)25/h1-11H,13H2,(H,24,26) | Definition date: | 2019-09-20 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 2-carbazol-9-yl-~{N}-(2-chloranyl-6-cyano-phenyl)ethanamide |
|
 | DYU | Name: | ~{N}-[2-(2,4-dimethylphenyl)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-3,4-dimethyl-benzamide | Formula: | C22 H23 N3 O S | SMILES: | Cc1ccc(n2nc3CSCc3c2NC(=O)c4ccc(C)c(C)c4)c(C)c1 | InChi: | InChI=1S/C22H23N3OS/c1-13-5-8-20(16(4)9-13)25-21(18-11-27-12-19(18)24-25)23-22(26)17-7-6-14(2)15(3)10-17/h5-10H,11-12H2,1-4H3,(H,23,26) | Definition date: | 2019-09-20 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | ~{N}-[2-(2,4-dimethylphenyl)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-3,4-dimethyl-benzamide |
|